BSE filing, NSE: KIRLOSELEC. Summary written from the filing by ALFA Finder's alert engine.
Envair Electrodyne Ltd: key numbers
- Share price
- ₹46.15
- Market cap
- ₹21.41 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹0.11 Cr
- P/E (TTM)
- 21365.7×Sector 52.0×
- Promoter holding
- 57.52%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Envair Electrodyne Ltd
All →Envair Electrodyne Other Announcement
Envair Electrodyne Ltd filed its quarterly shareholding pattern under Regulation 31 for the period ended September 30, 2026.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Limited conducted its 44th Annual General Meeting on September 29, 2026. Shareholders adopted audited financial statements and approved the re-appointment of directors and statutory auditors.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Ltd shareholders approved the sale/disposal of its overseas investment in Alliance Asia Pac Pte. Ltd., Singapore, via a postal ballot.
Envair Electrodyne Annual Report
Envair Electrodyne Ltd has filed its 44th Annual Report for the financial year 2025-26 and notice for the upcoming Annual General Meeting.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Ltd announced the outcome of its board meeting, scheduling the 44th Annual General Meeting for September 29, 2026. The board also approved the AGM notice and related reports.
Envair Electrodyne Annual General Meeting
Envair Electrodyne Limited has issued a postal ballot notice to seek shareholder approval for selling its overseas investment in Alliance Asia Pac Pte. Ltd., Singapore.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.